NEWS Biosyntia signs two further deals


Danish biotech Biosyntia has signed a contract with Germany’s Wacker Group to develop a large-scale production process for fermentation- based biotin based on Biosyntia’s technology. They aim for the material to be available “for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative”. It is currently only produced synthetically from petrochemicals. Also known as vitamin B7, biotin


is a coenzyme for the metabolism of proteins, fats and carbohydrates. Personal care is among its uses, though the largest is food and beverages. It also finds applications in infant nutrition, nutraceuticals, pet food, animal feed and pharmaceuticals. The market has


reportedly been growing at 10% year. Biosyntia has a proprietary


microbial technology platform, on which it is building a pipeline of active ingredients for the beauty and nutrition industries. Wacker, meanwhile, brings expertise in biotechnological process development and industrial-scale fermentation, which it already uses to produce L-cysteine. Biosyntia has also signed an


in-licensing deal with French white biotech firm Lantana Bio, to jointly develop production processes for flavonoids, also mainly in food applications but also personal care and others. Biosyntia will be responsible for bringing these processes into production and commercialising the ingredients.


Growth forecast for organic liquid soap market


A new study by Polaris Market Research forecasts that the global organic liquid soap should reach $135.1 million by 2028. Key factors driving this include their specific benefits of not harming the skin and even maintaining skin quality of skin as these products are made up of organic liquid substances derived from natural ingredients such as essential oils, glycerine, and plant-based oils.


The outbreak of COVID 19


has positively influenced the market, making consumers are more aware of their health. North America is expected to be the dominating region over the forecast period, because of health concerns. However, the Asia-Pacific is showing the highest CAGR, due to the increasing adoption of online trading.


Tilley-Phoenix buys Callahan


The New Jersey-based Tilley- Phoenix Group, which itself only came together in late 2021, has made its first subsequent acquisition in the form of its US compatriot Callahan Chemical Company. Both companies are distributors and service providers active in multiple industries including personal care. “Callahan, like Tilley-Phoenix,


brings a strong value-added approach to serving its suppliers and customers. The acquisition enhances the platform’s geographic reach, which is particularly compelling for our shared supplier base,” said Sean Tilley, president and COO of distribution at Tilley-Phoenix. Callahan, a second-


generation family-owned firm www.personalcaremagazine.com


dating back to 1958, is a regional distributor of ingredients and compounds to multiple end markets. It also offers such value- added services as regulatory and technical support, custom formulation, in-house laboratory QA and QC, blending, storage, packaging and repackaging. Tilley-Phoenix was formed


through the merger of Tilley and Phoenix Aromas & Essential Oils in 2021, under the ownership of SK Capital. It also distributes speciality ingredients to many different industries, with a similar range of services. The company added that it plans “to continue its pursuit of selective M&A, focused largely on specialty products sold into regulated markets”.


February 2022 PERSONAL CARE Flavonoids are a group of


actives that are present in several traditional Chinese medicine herbs with multiple claimed health benefits. The first to be developed is kaempferol, which will be the first fermented version on the world market.


“The jointly developed


technology platform will deliver today’s commercial flavonoids in a sustainable and natural way, and over time it has the potential to deliver thousands of high-quality flavonoids not previously possible to produce,” Biosyntia said.


New route to glitters


Researchers at Cambridge University have found new means to produce metre-long structurally coloured films that can be processed into effect pigments and glitters that are dispersible, even in water- based formulations. ‘Large-scale fabrication of structurally coloured cellulose nanocrystal films and effect pigments’, was published in Nature Materials in November 2021. The article details how the


cellulose nanocrystal self-assembly process, in which renewable plant- based colloidal particles can form photonic films, had hitherto been studied only on a small scale. The research team used roll-to-roll deposition to produce large-area photonic films, which required


the formulation of the cellulose nanocrystal suspension and the deposition and drying conditions to be optimised.


These suspensions are “are an


industrially relevant cellulose-based alternative to current products”, it is claimed. Current products are generally either micro-polluting, or based on carcinogenic, unsustainable or unethically sourced compounds, like titania or mica. The work was originally inspired


by the brilliant, metallic blue colour in the fruit of the marble berry plant (Pollia condensate). The glitters themselves were produced from wood-pulp and cotton but could potentially come from any plant material with extractable cellulose.


13


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84